药品注册申请号:084113
申请类型:ANDA (仿制药申请)
申请人:UPSHER SMITH LABS
申请人全名:UPSHER SMITH LABORATORIES LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Yes No AB 1974/07/09 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/02/05 SUPPL-122(补充) Approval Labeling STANDARD
2017/02/23 SUPPL-119(补充) Approval Labeling STANDARD
2016/08/29 SUPPL-118(补充) Approval Manufacturing (CMC) UNKNOWN
2011/09/13 SUPPL-114(补充) Approval Labeling
2010/12/03 SUPPL-111(补充) Approval Labeling
2009/08/24 SUPPL-108(补充) Approval Labeling
2008/11/19 SUPPL-105(补充) Approval Labeling
2002/11/25 SUPPL-90(补充) Approval Labeling
1999/03/22 SUPPL-89(补充) Approval Labeling
1999/03/22 SUPPL-88(补充) Approval Manufacturing (CMC)
1996/02/05 SUPPL-87(补充) Approval Manufacturing (CMC)
1992/09/16 SUPPL-86(补充) Approval Labeling
1991/12/31 SUPPL-85(补充) Approval Labeling
1990/11/29 SUPPL-84(补充) Approval Labeling
1989/02/14 SUPPL-83(补充) Approval Manufacturing (CMC)
1988/07/08 SUPPL-81(补充) Approval Manufacturing (CMC)
1988/04/26 SUPPL-82(补充) Approval Labeling
1988/04/14 SUPPL-79(补充) Approval Manufacturing (CMC)
1988/03/08 SUPPL-80(补充) Approval Labeling
1987/12/07 SUPPL-76(补充) Approval Manufacturing (CMC)
1987/12/07 SUPPL-75(补充) Approval Manufacturing (CMC)
1987/03/12 SUPPL-74(补充) Approval Manufacturing (CMC)
1986/07/10 SUPPL-73(补充) Approval Manufacturing (CMC)
1986/07/10 SUPPL-72(补充) Approval Manufacturing (CMC)
1986/03/11 SUPPL-70(补充) Approval Manufacturing (CMC)
1985/02/01 SUPPL-69(补充) Approval Manufacturing (CMC)
1984/04/10 SUPPL-65(补充) Approval Manufacturing (CMC)
1982/04/26 SUPPL-63(补充) Approval Manufacturing (CMC)
1974/07/09 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CHLORPROMAZINE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:50MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
084113 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription Yes No AB Approved Prior to Jan 1, 1982 UPSHER SMITH LABS
209755 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2018/09/10 AMNEAL PHARMS CO
213368 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2020/01/17 ZYDUS
213590 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2020/08/31 APPCO
214256 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2020/10/26 SUN PHARM
212996 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2021/01/22 LANNETT CO INC
212144 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2021/03/23 GLENMARK PHARMS LTD
215659 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2021/10/25 TEVA PHARMS
212630 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2021/11/29 ZAMEER PHARMS
214827 002 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2022/01/27 MSN
213327 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2023/07/13 LUPIN
217350 003 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL 50MG Prescription No No AB 2023/07/18 ALEMBIC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database